Objectives To describe disease activity 30 years after disease onset in a previously studied
cohort of patients with juvenile idiopathic arthritis (JIA) and reveal predictors of long-term …

Abstract Purpose of Review This review assesses the long-term remission and predictors of
clinical outcome in patients with juvenile idiopathic arthritis (JIA). A comprehensive literature …

With advancing therapeutic options, achieving a state of remission has become the
treatment goal in rheumatoid arthritis. Agreeing on what constitutes remission and what …

Objectives Many criteria for clinically inactive disease (CID) and minimal disease activity
(MDA) have been proposed for juvenile idiopathic arthritis (JIA). It is not known to what …

Background There is a lack of published evidence on the importance of methotrexate (MTX)
dose and route of administration on both its efficacy and adverse events in children with …

Objectives To describe the disease characteristics, continuous course and long-term
outcome and to evaluate predictors of outcome in JIA in Greece. Methods We performed a …

Objectives: To evaluate the safety and efficacy of adalimumab (AD) administration in
patients with juvenile idiopathic arthritis (JIA). Methods: Twenty-six patients were enrolled …

Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory arthritic disease
affecting children. Despite the availability of potent disease-modifying antirheumatic …

The aim of the study was to assess the presence and characteristics of subclinical synovitis
using power Doppler (PD) ultrasonography on patients with juvenile idiopathic arthritis (JIA) …

Background Juvenile idiopathic arthritis (JIA) is challenging to classify and effectively
monitor due to the lack of disease-and subtype-specific biomarkers. A robust molecular …